FEBUXOSTAT

You have access
Hepatic Safety of Febuxostat Compared with Allopurinol in Gout Patients with Fatty Liver Disease
Jung Sun Lee, Jebum Won, Oh Chan Kwon, Seung Soo Lee, Ji Seon Oh, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo and Seokchan Hong

The Journal of Rheumatology May 1 2019, 46 (5) 527-531; DOI: https://doi.org/10.3899/jrheum.180761
Open Access
The Pharmacodynamics, Pharmacokinetics, and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout
Alexandra S. Steinberg, Bradley D. Vince, Yun-Jung Choi, Robert L. Martin, Charles A. McWherter and Pol F. Boudes

The Journal of Rheumatology March 1 2017, 44 (3) 374-379; DOI: https://doi.org/10.3899/jrheum.161062
You have access
Urate-Lowering Therapy for the Management of Gout: A Summary of 2 Cochrane Reviews
Alison S. Kydd, Rakhi Seth, Rachelle Buchbinder, Louise Falzon, Christopher J. Edwards, Désirée M. van der Heijde and Claire Bombardier

The Journal of Rheumatology Supplement September 1 2014, 92 33-41; DOI: https://doi.org/10.3899/jrheum.140460
You have access
Treatment of Gout Patients with Impairment of Renal Function: A Systematic Literature Review
Irene A. van Echteld, Caroline van Durme, Louise Falzon, Robert B. Landewé, Désirée M. van der Heijde and Daniel Aletaha

The Journal of Rheumatology Supplement September 1 2014, 92 48-54; DOI: https://doi.org/10.3899/jrheum.140462

Main menu